glp-1 and muscle mass The Muscle-Loss Debate Is Asking the Wrong Question GLP-1 Receptor Agonists for Obesity

14 (3) e0214585

While not FDA-approved as a complete product, the individual components of Lipo-C are recognized for their safety and efficacy in metabolic processes

Microdosing protocols: what practitioners are actually using No FDA-approved indication exists for GLP-1 microdosing in autoimmune disease

In a retrospective cohort study of 16,827 patients in a single-center neuroophthalmology clinic, Hathaway et al found that semaglutide use was significantly associated with an increased incidence of NAION among patients with diabetes (HR = 4.28)

845 Transcriptomic analyses of patients with intestinal I/R injury and mice showed that ferroptosis-related genes such as IL-6, CXCL2, HMOX1, GDF15, HSPA5, and TNFAIP3, may be hub genes in intestinal I/R injury

Other uses of cyanocobalamin include treating memory loss, fatigue, neurological disorders, depression, and fatigue associated with certain chronic conditions such as HIV and diabetes